Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...

Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...

TPG acquires 35% stake in SCHOTT Poonawalla from Serum Institute of India; SCHOTT Pharma retains 50% while SII continues as ...

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

TPG is making the investment along with Danish firm Novo Holdings as a co-investor. SII, the world's largest vaccine maker, ...

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is ...

TPG will acquire a 35% stake in SCHOTT Poonawalla from the Serum Institute of India. This joint venture with SCHOTT Pharma is ...

TPG has entered into a binding agreement to acquire 35% stake in Schott Poonawalla from Serum Institute of India (SII), said ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...

The transaction, funded through TPG Growth and co-investor Novo Holdings, is expected to close in the first half of 2025.